Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 437 results found. Search for [ astrazeneca covid 19 vaccine ]

Results 1 to 21 of 437
Associated Press
November 30, 2020
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the US and Europe. US hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day


Chitranjan Kumar
November 30, 2020
Primary efficacy analysis of the Phase 3 COVE study of Moderna' COVID-19 vaccine involved 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe


BusinessToday.In
November 30, 2020
PM Modi asks teams to come out with ideas on regulatory processes and related matters. As pharma companies move ahead with their clinical trials, the government has also stepped up efforts to devise the vaccine distribution plan


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


Reuters
November 30, 2020
A 40-year-old man said that he had suffered serious \"neurological and psychological\" symptoms after receiving the vaccine in a trial being run by the British drugmaker's partner Serum Institute of India (SII)


PTI
November 29, 2020
After making rounds everywhere in the world, the vaccine on COVID-19 would be found in Pune. Nothing is beyond Pune, the Baramati MP said


BusinessToday.In
November 29, 2020
Poonawallathanks PM Modi for visiting the institute; says SII shares his vision and continues to work towards ensuring a safe and secure India. SII may apply for emergency use authorisation of its vaccine in the next two weeks


BusinessToday.In
November 29, 2020
As coronavirus cases continue to rise, the UK plans to move fast in the approval process and clearance to Pfizer and BioNTech SE could come by next week


BusinessToday.In
November 29, 2020
Serum Institute of India's (SII) CEO Adar Poonawalla made the announcement hours after a meeting with Prime Minister Narendra Modi, who visited Serum's plant in Pune on Saturday, November 28


Reuters
November 28, 2020
Poonawalla said in the next few weeks SII plans to apply for emergency use authorization for AstraZeneca's COVID-19 vaccine candidate that he described as a 'very good' option


BusinessToday.In
November 28, 2020
PM Modi paid his visit to Pune-based Serum Institute of India and reviewed the manufacturing process of COVID-19 vaccine. He interacted with scientists at the SII and went around the facility, taking stock of vaccine development work


BusinessToday.In
November 28, 2020
The British-Swedish drug maker AstraZeneca would also submit the current data set to the Indian regulator within the stipulated time, and also provide additional study results


PTI
November 28, 2020
PM Modi landed at Hakimpet Air Force station near here at around 1 pm,as part of his three-city tour to take the stock of COVID-19 vaccine development


BusinessToday.In
November 28, 2020
Delhi Health Minister Satyendra Jain also said that the vaccination will be administered to all people residing in the National Capital with the help of health facilities such as polyclinics


Reuters
November 28, 2020
Germany's Economy Minister Peter Altmaier said it was not possible to give the all-clear while there were incidences of more than 50 infections per 100,000 inhabitants in large parts of the country


Reuters
November 28, 2020
If a vaccine has an efficacy of, say, 80%, it means that if 100 people who have not previously been infected by the coronavirus are given the vaccine, on average 80 of them will not get the disease that the virus causes: COVID-19


BusinessToday.In
November 28, 2020
PM Modi took stock of the work being done so far on the development of coronavirus vaccine at the Zydus Cadila research centre


Reuters
November 28, 2020
Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of \"cutting corners\", said Thomas Cueni, director-general of the IFPMA


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


BusinessToday.In
November 27, 2020
Gadkari claimed that accidents and deaths due to it have been reduced by almost 20 per cent. He also said that the government is developing a portal for providing real-time updates on black spots on highways in a bid to reduce road accidents


PAGES 1 OF 22  12345